3.23.21-Health-Ernest-Fraenkel

• Video details

  Rates of dementia and neurodegeneration are accelerating, with no therapies in sight despite record numbers of clinical trials.  New approaches are desperately needed, built on radically different research paradigms.  The convergence of new technologies at the interface of biological engineering and computer science create an opportunity for a fresh start.  I’ll describe a large-scale effort to understand and develop therapies for the neurodegenerative disease ALS.  Our approach uses Artificial Intelligence to integrate clinical and molecular data, and can serve as a model for addressing other neurodegenerative diseases.

Locked Interactive transcript